UPDATE : Friday, January 17, 2020
상단여백
‘Endogenous T cells have high potential of treating blood, solid tumors’
A variety of adoptive T-cell therapeutic strategies has shown a remarkable ...
by Lee Han-soo  |  2019-12-06 12:41
라인
Korea exports health insurance system to Bahrain
The Korean government has completed establishing a health insurance system ...
by Kwak Sung-sun  |  2019-12-05 16:12
라인
‘Lynparza raises value of precision medicine as anticancer treatment’
AstraZeneca’s Lynparza (ingredient: olaparib), the first PARP (poly ADP rib...
by Kim Yun-mi  |  2019-12-05 16:05
라인
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Celltrion Healthcare said that it has become the first local biopharmaceuti...
by Lee Han-soo  |  2019-12-05 15:04
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
Roche Diabetes Care emphasized the importance of “integrated personalized d...
by Park Gi-taek  |  2019-12-05 13:01
라인
Macrogen’s research on Asian genomic database becomes cover story of Nature
Macrogen said that it presented the result of its Asian genome analysis, wh...
by Lee Han-soo  |  2019-12-05 11:54
라인
‘Obesity treatment will drastically change next few years’
An Irish expert on obesity and diabetes said Wednesday that prospects for t...
by Lee Han-soo  |  2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients'
In Korea, 20.9 percent of diabetic patients, who have a hemoglobin A1c (HbA...
by Lee Han-soo  |  2019-12-04 17:07
라인
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im  |  2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
Hanmi Pharmaceutical said that it has licensed in FLX475, the world’s first...
by Lee Han-soo  |  2019-12-04 16:16
라인
ISU Abxis starts trial of Gaucher disease treatment in Australia
ISU Abxis said that it has started phase 1 clinical trial of Abcertin, an e...
by Lee Han-soo  |  2019-12-04 16:16
라인
Korean patient with rare breast cancer to sue Allergan in US
A Korean patient who developed rare cancer after receiving Allergan’s speci...
by Song Soo-youn  |  2019-12-04 14:49
라인
Drugmakers strongly oppose post-approval evaluation
The pharmaceutical industry adamantly criticized the government’s plan to e...
by Kim Eun-young  |  2019-12-04 13:17
라인
Swedish researchers divide Type 2 diabetes into 5 subgroups
A Swedish research team has divided type 2 diabetes patients into smaller h...
by Lee Han-soo  |  2019-12-03 17:45
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
Samyang Biopharm USA said Tuesday it has signed a deal to adopt a new immun...
by Jeong Sae-im  |  2019-12-03 15:37
라인
Technology developed to detect inflammatory disorders early
Local researchers said they have developed a technology that can monitor an...
by Song Soo-youn  |  2019-12-03 15:35
라인
Ildong signs co-promotion contract with GSK Consumer Healthcare
Ildong pharmaceutical said that it will co-promote GSK Consumer Healthcare’...
by Lee Han-soo  |  2019-12-03 15:18
라인
Quick test for meningitis unavailable due to low reimbursement
“I heard there is a quick test for meningitis. Where can I get it?”A patien...
by Song Soo-youn  |  2019-12-03 13:24
라인
Global diabetes group opens 5-day show in Busan
The International Diabetes Federation (IDF) 2019 conference kicked off for ...
by Lee Han-soo  |  2019-12-03 11:04
라인
‘Obesity needs to be treated as a chronic disease’
Countries have to face the fact that obesity is a chronic disease and that ...
by Lee Han-soo  |  2019-12-02 18:02
여백
여백
여백
Back to Top